Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model

Chinese Medical Journal

Volumn 122, Issue 12, 2009, Pages 1423-1428

  Mi, Ya Fei ^a,b   Li, Xiao Ying ^b   Tang, Li Jiang ^a   Lu, Xiao Chun ^b   Fu, Zhi Qing ^b   Ye, Wei Hua ^b  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Gene therapy; Heart failure; Sarco endoplasmic reticulum calcium ATPase

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR GENE THERAPY; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG MECHANISM; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; INTRACARDIAC ECHOCARDIOGRAPHY; NONHUMAN; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DOGS; ECHOCARDIOGRAPHY; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HEART; HEART FAILURE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 68249145908     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.12.013     Document Type: Article

References (19)

1. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol 2002; 34: 951-969.
2. Piacentino V 3rd, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM, et al. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 2003; 92: 651-658.
3. Hoshijima M. Gene therapy targeted at calcium handling as an approach to the treatment of heart failure. Pharmacology Therapeutics 2005; 105: 211-228.
4. del Monte F, Hajjar R. Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol 2003; 546: 49-61.
5. Wehrens XH, Marks AR. Novel therapeutic approaches for heart failure by normalizing calcium cycling. Nat Rev Drug Discov 2004; 3: 565-573.
6. Hasenfuss G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 1998; 39: 60-76.
7. 2+-ATPase and phospholamban in the failing and nonfailing heart. Cardiovas Res 2000; 45: 245-252.
8. Frank KF, Bölck B, Brixius K, Kranias EG, Schwinger RH. Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol 2002; 97: I72- I78.
9. 2+-ATPase in a rat model of heart failure. Circulation 2001; 104: 1424-1429.
10. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A 2000; 97: 793-798.
11. Hirsch JC, Borton AR, Albayya FP, Russell MW, Ohye RG, Metzger JM. Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction. Am J Physiol Heart Circ Physiol 2004; 286: H2314-H2321.
12. Li XY, Hui HP, Lu XC, Guo YT. Treatment of chronic heart failure by overexpressing sarcoplasmic reticulum calcium ATPase through gene therapy: an experiment with rats. Natl Med J China (Chin) 2006; 86: 1174-1178.
13. Yan H, Guo Y, Zhang P, Zu L, Dong X, Chen L, et al. Superior neovascularization and muscle regeneration inischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectoers. Biochem Biophys Res Commun 2005; 336: 287-298.
14. Kawase Y, Ly HQ, Prunier F, Shi Y, Jin H, Hadri L, et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 2008; 51: 1112-1119.
15. Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, et al. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 2007; 115: 2506-2515.
16. Chu D, Sullivan CC, Weitzman MD, Du L, Wolf PL, Jamieson SW, et al. Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. J Thorac Cardiovasc Surg 2003; 126: 671-679.
17. Du L, Kido M, Lee DV, Rabinowitz JE, Samulski RJ, Jamieson SW, et al. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors. Mol Ther 2004; 10: 604-608.
18. Deng XL, Wu XB, Jiang J, Guo YH, Yan H, Shi B, et al. Recombinant adeno-associated viral vector 2-mediated gene transfer of VEGF165 improved porcine chronic myocardial ischemia. Chin J Cardiol (Chin) 2005; 33: 732-737.
19. Svensson EC, Marshall DJ, Woodard K, Lin H, Jiang F, Chu L, et al. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adenoassociated virus vectors. Circulation 1999; 99: 201-205.